APA (7th ed.) Citation

Y, Z., K, L., L, S., S, S., Q, X., H, E., . . . N, B. (2024). FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma. Nature communications, 15(1), 3805. https://doi.org/10.1038/s41467-024-47514-y

Chicago Style (17th ed.) Citation

Y, Zhen, et al. "FGFR Inhibition Blocks NF-ĸB-dependent Glucose Metabolism and Confers Metabolic Vulnerabilities in Cholangiocarcinoma." Nature Communications 15, no. 1 (2024): 3805. https://doi.org/10.1038/s41467-024-47514-y.

MLA (9th ed.) Citation

Y, Zhen, et al. "FGFR Inhibition Blocks NF-ĸB-dependent Glucose Metabolism and Confers Metabolic Vulnerabilities in Cholangiocarcinoma." Nature Communications, vol. 15, no. 1, 2024, p. 3805, https://doi.org/10.1038/s41467-024-47514-y.